Performance Evaluation of Blood Glucose Monitoring Systems
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The goal of this single-center, comparative, open label, in-vitro diagnostic device
performance evaluation was to investigate the performance of two sanofi-aventis BGMSs
(BGStar® and iBGStar®) with regard to system accuracy (Polaris), precision and Hct influence
(Helios).
Phase:
Phase 4
Details
Lead Sponsor:
IKFE Institute for Clinical Research and Development